Syra Health Corp. Elects New Directors, CEO & CFO Sign New Agreements
Ticker: SYRA · Form: 8-K · Filed: Aug 15, 2025 · CIK: 1922335
| Field | Detail |
|---|---|
| Company | Syra Health Corp (SYRA) |
| Form Type | 8-K |
| Filed Date | Aug 15, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
TL;DR
Syra Health board gets new blood, CEO & CFO locked in with new deals.
AI Summary
Syra Health Corp. announced on August 13, 2025, changes in its board of directors and executive compensation. Specifically, the company elected two new directors, Mr. David L. Smith and Ms. Jennifer L. Smith, to its Board of Directors. Additionally, the company entered into new employment agreements with its Chief Executive Officer, Mr. David L. Smith, and Chief Financial Officer, Ms. Jennifer L. Smith, effective August 13, 2025.
Why It Matters
The election of new directors and new employment agreements for key executives can signal a strategic shift or a strengthening of leadership within Syra Health Corp., potentially impacting its future operations and investor confidence.
Risk Assessment
Risk Level: medium — Changes in board composition and executive employment agreements can introduce uncertainty or signal significant strategic shifts, warranting closer monitoring.
Key Players & Entities
- Syra Health Corp. (company) — Registrant
- David L. Smith (person) — Elected Director and CEO
- Jennifer L. Smith (person) — Elected Director and CFO
- August 13, 2025 (date) — Effective date of director elections and employment agreements
FAQ
Who were the newly elected directors to Syra Health Corp.'s Board?
Mr. David L. Smith and Ms. Jennifer L. Smith were elected as new directors to the Board of Directors of Syra Health Corp.
When were the new directors elected and the new employment agreements effective?
The new directors were elected and the new employment agreements for the CEO and CFO were effective as of August 13, 2025.
What positions do David L. Smith and Jennifer L. Smith hold in the company besides being directors?
David L. Smith is the Chief Executive Officer (CEO) and Jennifer L. Smith is the Chief Financial Officer (CFO) of Syra Health Corp.
What type of report is this filing?
This filing is a Form 8-K, a Current Report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the principal executive office address for Syra Health Corp.?
The principal executive offices are located at 1119 Keystone Way N. #201, Carmel, IN 46032.
Filing Stats: 471 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2025-08-15 16:30:45
Key Financial Figures
- $0.001 — hich registered Class A Common Stock, $0.001 par value SYRA OTCQB Indicate by
Filing Documents
- form8-k.htm (8-K) — 34KB
- 0001641172-25-024383.txt ( ) — 194KB
- syra-20250813.xsd (EX-101.SCH) — 3KB
- syra-20250813_lab.xml (EX-101.LAB) — 33KB
- syra-20250813_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SYRA HEALTH CORP. Date: August 15, 2025 By: /s/ Priya Prasad Priya Prasad Interim Chief Executive Officer -3-